FDA 483 - Neogen Culture Media - April 07, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Neogen Corporation in Lansing, MI, revealed significant deficiencies in their medical device quality system. The firm failed to adequately establish procedures for corrective and preventive actions, process validation, complaint handling, design changes, product identification, supplier control, device history records, and device master records. Several critical observations, including those related to CAPA and process validation, were repeat findings from previous inspections.
ID · 3576a69e-7592-4909-ba12-94e908187dc0